Immunexpress
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
425 Pontius Ave N Ste 470, Seattle, Wash...Phone Number
(206) 858-6436Website
www.immunexpress.comRevenue
<$5 MillionIndustry
About Immunexpress
Immunexpress is a molecular diagnostic company focused on enhancing outcomes for patients suspected of having sepsis and supporting healthcare providers. The company has developed the SeptiCyte RAPID technology, which allows for the rapid detection of sepsis by analyzing the immune response, providing results in just one hour. This innovative approach aims to improve clinical and economic outcomes for patients while benefiting medical professionals and payers. Immunexpress is dedicated to revolutionizing sepsis diagnosis and management through advanced molecular diagnostics.Explore more
Immunexpress Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Immunexpress
Compare insights from companies similar to Immunexpress, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immunexpress Tech Stack
A closer look at the technologies used by Immunexpress
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunexpress
Sign Up For FreeTo access detailed company insights
Immunexpress is a molecular diagnostic company focused on enhancing outcomes for patients suspected of having sepsis and supporting healthcare providers. The company has developed the SeptiCyte RAPID technology, which allows for the rapid detection of sepsis by analyzing the immune response, providing results in just one hour. This innovative appro... Read More
